ArticleEuropean geriatric medicine2026
Association of implementation of secondary fracture prevention incentives after hip fracture and risk of subsequent fracture in real-world practice.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSecondary fracture prevention (SFP) after hip fracture is recommended in clinical guidelines but implementation remains suboptimal in routine practice. Financial incentives linked to SFP management have been introduced to address implementation gaps; however, whether such strategies reduce subsequent fractures in routine practice remains unclear. We evaluated the association between receipt of SFP incentives and subsequent fractures and explored factors associated with implementation.
methodsThis nationwide retrospective cohort study using Japanese administrative claims data included 11,147 patients aged 60 years or older who underwent hip fracture surgery. The primary outcome was major osteoporotic fracture within 12 months, analyzed using Fine-Gray models accounting for the competing risk of death. Facility-level factors associated with acute-care incentive billing were examined using multilevel Poisson regression.
resultsOverall, 4,019 patients (36.1%) received acute-care SFP incentives during the index hospitalization. Receipt of the acute-care incentive was associated with a 15% lower risk of subsequent fractures (subdistribution hazard ratio, 0.85; 95% confidence interval, 0.73 to 0.99). Incentive uptake was associated with hospital-level characteristics reflecting prior osteoporosis care performance, including Diagnosis Procedure Combination participation (risk ratio, 2.11; 95% confidence interval, 1.45 to 3.08) and higher prior-year osteoporosis assessment rates. Continuity of post-discharge management was limited: 66.0% of recipients had no subsequent incentive claims, and cumulative post-discharge claims were not associated with additional fracture risk reduction.
conclusionAcute-care SFP incentives were associated with lower fracture risk in routine practice, but implementation and continuity were suboptimal, highlighting the need to improve SFP implementation across the post-fracture care pathway.
Indexed as
Identifiers
42579041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.